NIH Funding Opportunities and Notices for The Week Ending12-11-2020

NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required)
(PAR-21-063)
National Institute on Deafness and Other Communication Disorders
Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is February 5, 2021.
NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)
(PAR-21-064)
National Institute on Deafness and Other Communication Disorders
Application Receipt Date(s): February 10, 2021; June 10, 2021; October 13, 2021; February 10, 2022; June 10, 2022; October 11, 2022; February 10, 2023; June 9, 2023 and October 10, 2023
Mentored Research Experiences for Genetic Counselors (R25)
(PAR-21-074)
National Human Genome Research Institute
Application Receipt Date(s): May 25, 2021, May 25, 2022, and May 25, 2023.
Research Experiences in Genomic Research for Data Scientists (R25)
(PAR-21-075)
National Human Genome Research Institute
Application Receipt Date(s): May 25, 2021; May 25, 2022; May 25, 2023.
NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 Clinical Trial Required)
(PAR-21-085)
National Institute on Deafness and Other Communication Disorders
Application Receipt Date(s): February 17, 2021; June 17, 2021; October 13, 2021; February 17, 2022; June 14, 2022; October 13, 2022; February 14, 2023; June 13, 2023; October 13 2023, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 No Independent Clinical Trials)
(PAR-21-086)
National Institute on Deafness and Other Communication Disorders
Application Receipt Date(s): February 17, 2021; June 17, 2021; October 13, 2021; February 17, 2022; June 14, 2022; October 13, 2022; February 14, 2023; June 13, 2023; October 13, 2023 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 Independent Basic Experimental Studies with Humans Required)
(PAR-21-087)
National Institute on Deafness and Other Communication Disorders
Application Receipt Date(s): February 17, 2021; June 17, 2021; October 13, 2021; February 17, 2022; June 14, 2022; October 13, 2022; February 14, 2023; June 13, 2023; October 13, 2023, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)
(PAR-21-097)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): February 19, 2021, June 17, 2021, October 19, 2021, February 17, 2022, June, 17, 2022, October 18, 2022, February 17, 2023, June 19, 2023, October 17, 2023
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
(PAR-21-098)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): February 19, 2021, June 17, 2021, October 19, 2021, February 17, 2022, June, 17, 2022, October 18, 2022, February 17, 2023, June 19, 2023, October 17, 2023
Aging Effects on Osteoimmunology (R01 Clinical Trials Not Allowed)
(RFA-AG-22-002)
National Institute on Aging
Application Receipt Date(s): June 15, 2021
NIAMS Centers of Research Translation (CORT) (P50 - Clinical Trial Not Allowed)
(RFA-AR-22-001)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date(s): May 11, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Cellular Cancer Biology Imaging Research (CCBIR) Program (U54, Clinical Trial Not Allowed)
(RFA-CA-21-002)
National Cancer Institute
Application Receipt Date(s): March 18, 2021 No late applications will be accepted for this Funding Opportunity Announcement All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Application of Artificial Intelligence and Machine Learning for Advancing Environmental Health Sciences (R43 Clinical Trial Not Allowed)
(RFA-ES-21-002)
National Institute of Environmental Health Sciences
Application Receipt Date(s): March 29, 2021
Application of Artificial Intelligence and Machine Learning for Advancing Environmental Health Sciences (R41 Clinical Trial Not Allowed)
(RFA-ES-21-003)
National Institute of Environmental Health Sciences
Application Receipt Date(s): March 29, 2021
Renewal - Research, Education, and Outreach on Botanical Natural Products (U01) Clinical Trial Not Allowed
(RFA-FD-21-010)
Food and Drug Administration
Application Receipt Date(s): February 12, 2021 by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
Physiologically-based pharmacokinetic (PBPK) models to aid the development of generic dermatological products (U01) Clinical Trials Optional
(RFA-FD-21-013)
Food and Drug Administration
Application Receipt Date(s): February 18, 2021 by 11:59 PM Eastern Time.
Development of Methods to Evaluate the Impact of Design Differences to the User Interface of Generic Drug-Device Combination Products in Comparison to their Reference Listed Drugs (U01) Clinical Trials Optional
(RFA-FD-21-014)
Food and Drug Administration
Application Receipt Date(s): February 15, 2021 by 11:59 PM Eastern Time.
Mood Disorders in People Living with HIV: Mechanisms and Pathways (R01 Clinical Trial Optional)
(RFA-MH-21-116)
National Institute of Mental Health
Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
Mood Disorders in People Living with HIV: Mechanisms and Pathways (R21 Clinical Trial Optional)
(RFA-MH-21-117)
National Institute of Mental Health
Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional)
(RFA-RM-20-022)
Office of Strategic Coordination (Common Fund)
Application Receipt Date(s): March 1, 2021 No late applications will be accepted for this Funding Opportunity Announcement. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Coordination and Evaluation Center (U24 Clinical Trial Not Allowed)
(RFA-RM-20-023)
Office of Strategic Coordination (Common Fund)
Application Receipt Date(s): March 1, 2021 No late applications will be accepted for this Funding Opportunity Announcement.
New Chemistries for Un-drugged Targets through A Specialized Platform for Innovative Research Exploration (ASPIRE) Collaborative Research Program (UG3/UH3 Clinical Trials Not Allowed)
(RFA-TR-21-001)
National Center for Advancing Translational Sciences
Application Receipt Date(s): July 8, 2021. No late applications will be accepted for this Funding Opportunity Announcement.
Virtual Approaches Towards New Chemistries for Un-drugged Targets through A Specialized Platform for Innovative Research Exploration (ASPIRE) Collaborative Research Program (U18 Clinical Trials Not Allowed)
(RFA-TR-21-002)
National Center for Advancing Translational Sciences
Application Receipt Date(s): July 8, 2021 No late applications will be accepted for this Funding Opportunity Announcement.